很遺憾，我們無法支援你的瀏覽器。如果可以，請升級到新版本，或使用 Mozilla Firefox、Microsoft Edge、Google Chrome 或 Safari 14 或更新版本。如果無法升級，而且需要支援，請將你的回饋寄給我們。
我們衷心感謝你對這個新體驗的回饋。告訴我們你的想法(打開新的分頁／視窗)
Find the best strategy for your drug candidates’ safety and efficacy. Reduce animal testing. Go to market faster with safer life-transforming treatments for patients. Trusted by the FDA, PMDA and the world’s top 20 pharma companies.
Find powerful preclinical and clinical data and tools for the translation to humans
Benchmark against approved and withdrawn drugs with the same mechanism of action as your drug candidates
Predict:
Adverse effects
Animal models
Clinical endpoints
The more you find and predict, the less animal testing you need.
Predict fast and effective strategies for the success of all regulatory submissions
Use PharmaPendium to minimize regulatory cycling and avoid failing approval
Find information about previous regulatory submissions and profit from precedents to predict agencies’ requirements
"... PharmaPendium excels in retrieving specific toxicity observations across approval documents categorized by drug and species."
GB
Guy Bouvier, PhD, ERT
Groupe Pierre Fabre 的 Director, Toxicology & Product Safety
Continuous development and improvement of PharmaPendium has been achieved in collaboration with the FDA for 17 years, as well as with leading pharma partners like Novartis, Sanofi, Merck, Servier and Boehringer Ingelheim.
PharmaPendium is used by:
Toxicologists and safety pharmacologists
DMPK specialists
Clinical researchers
Regulatory affairs experts
Global patient safety experts
Data scientists
PharmaPendium provides you with unique content, all in one place. PharmaPendium data sources include:
Full FDA approval packages
Full EMA approval documents
FDA Advisory Committee Documents
FDA Adverse Event Reporting System (FAERS)
FDA classic collection (covering 1938-1991)
DESI (Drug Efficacy Study Implementation) documents
Meyler's 16th Edition
Mosby's Drug Consult™️
Scientific articles
We extract, organize, connect and continually update a wide variety data in PharmaPendium. Get the latest content statistics for PharmaPendium(打開新的分頁／視窗).
PharmaPendium includes safety, PK, MET, efficacy, activity, FAERS and drug data, as well as approval packages and documents from the FDA and EMA.
PharmaPendium and Embase combined empower you to find additional indications for drug repurposing of unapproved or approved drugs. With the breadth of data in Embase and PharmaPendium, you can find relevant clinical studies and data to predict the requirements of clinical trial design and to mitigate risk. In addition to data on approved drugs in PharmaPendium, Embase provides information on unapproved drugs. Embase covers more than 8,500 scientific journals and millions of abstracts from 11,500 conferences worldwide.
